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This paper  provides  an  overview  of  the  Saguenay  Youth  Study  (SYS)  and  its parental  arm.  The
overarching  goal  of  this  effort  is to  develop  trans-generational  models  of  developmental
cascades  contributing  to  the  emergence  of  common  chronic  disorders,  such  as  depres-
sion, addictions,  dementia  and  cardio-metabolic  diseases.  Over  the  past  10 years,  we  have
acquired  detailed  brain  and cardio-metabolic  phenotypes,  and  genome-wide  genotypes,  in
1029 adolescents  recruited  in  a population  with  a known  genetic  founder  effect.  At present,
we are  extending  this  dataset  to acquire  comparable  phenotypes  and  genotypes  in the  bio-
logical parents  of these  individuals.  After  providing  conceptual  background  for  this  workiddle age
RI
rain
ental  health
ddiction
(transactions  across  time,  systems  and organs),  we  describe  brieﬂy  the  tools  employed  in
the adolescent  arm  of  this  cohort  and  highlight  some  of  the  initial  accomplishments.  We
then  outline  in  detail  the phenotyping  protocol  used  to acquire  comparable  data  in the
parents.
© 2014  The  Authors.  Published  by Elsevier  Ltd.  This  is  an  open  access  article  under  the  CC
BY license  (http://creativecommons.org/licenses/by/3.0/).. IntroductionThe last century witnessed a dramatic growth in life
xpectancy. In the Unites States of America, life expectancy
ncreased from an average of 44.8/47.8 (men/women) years
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878-9293/© 2014 The Authors. Published by Elsevier Ltd. This is an open 
icenses/by/3.0/).in 1900 to an average of 73.9/79.4 years in 1998 (Smith
and Bradshaw, 2006), owing mainly to the development of
treatments  of infectious diseases and the management of
cardiovascular disorders and cancers (Guyer et al., 2000).
Unfortunately, this increase in life expectancy has not been
paralleled by increases in healthy life expectancy, deﬁned
as  years lived without a disability. In 2002, the global
(194 countries) gap between life expectancy and health-
adjusted life expectancy was  7.5 years (Mathers et al.,
2004). In developed countries, the main causes of Years
Lived  with Disability (YLD) – a metric used to calculate
health-adjusted life expectancy – are non-communicable
access article under the CC BY license (http://creativecommons.org/
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diseases (86.2% of all causes), with psychiatric conditions
contributing the most (41.9%) to the overall health bur-
den  (Mathers et al., 2004). Among the latter conditions,
unipolar depressive disorder (15%), alcohol abuse (6.8%)
and  Alzheimer’s disease and other dementias (4.2%) stand
out  as the major causes of YLD. Although the increased
prevalence of dementias is in part a reﬂection of longer life
span,  a cumulative impact of poor cardio-metabolic health
on  brain health is also one of the key mechanistic pathways
leading to dementia (see below).
One of the main reasons for the high health-burden
associated with psychiatric disorders, such as depres-
sion and substance use, but also schizophrenia (2.3%) and
bipolar  disorder (2.2%), is their early onset and chronic
course, resulting in a large accumulation of YLD over
time (Fig. 1).
For  this reason, our quest to understand the causes
and pathways leading to psychiatric disorders must take
a  developmental perspective. This perspective acknowl-
edges the complexity of developmental cascades – and
ensuing transactions – playing out over time, across lev-
els  and between organs (Masten and Cicchetti, 2010).
In  the following text, we will review brieﬂy these three
elements of developmental cascades in order to provide
context for the design of the Saguenay Youth Study (SYS).
We  will conclude this section by providing motivation
for expanding the SYS to include a multi-generational
arm.
Fig. 1. Ranges of onset age (top) and years lived with disability (bottom) for com
Bottom  ﬁgure based on data from (Whiteford et al., 2013). Percentages indicate
substance  use disorder group in 2010 (100% = all psychiatric disorders).euroscience 11 (2015) 129–144
1.1. Developmental cascades and transactions
1.1.1. Transactions over time is perhaps the best-
understood long-term driver of health: a cascade starting
in  pregnancy and early post-natal development, pro-
gressing through “preclinical” stages of a disease (e.g.,
in  adolescence), and ending in a disease with its fully
expressed manifestations (e.g., in adulthood). Let us
illustrate this concept with two seminal studies of the
relationship between early environment and adult health.
In  experimental settings, Meaney and colleagues have
demonstrated that maternal care (licking and grooming
of  pups) has a striking impact on the hypothalamus-
pituitary-adrenal axis (HPA) and stress reactivity of
the  offspring (Liu et al., 1997). This, in turn, sets in
motion a number of pathophysiological processes leading
ultimately to poor mental and physical health (Fig. 2).
Using  an epidemiological approach, Barker discovered
an association between birth weight and cardiovascular
mortality in adulthood (Barker et al., 1989). Here, a cascade
initiated in utero and in early post-natal life may  exert a
domino  effect on cardio-metabolic health of the offspring
for  the rest of his/her life (Plagemann, 2006). These are
two  examples of early “programming” of the brain and
body  systems, with powerful long-term consequences
for mental and cardio-metabolic health. Not surprisingly,
many scholars interested in long-term consequences
of early adversity have embraced the hypothesis of
mon psychiatric disorders. Top ﬁgure adapted from (Paus et al., 2008a).
 proportion of years lived with disability explained by each mental and
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Fig. 2. Associations between maternal behavior (licking and grooming), expression of the glucocorticoid receptor in the hippocampus, regulation of the
hypothalamus-pituitary-adrenal axis and psychopathology (right side). From (Zhang et al., 2013). LG, licking and grooming; ACTH, adrenocorticotropin;
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lRF, corticotropin releasing factor; 5-HT, serotonin; camp, cyclic adenosin
actor  A; CBP, CREB-binding protein; GR, glucocorticoid receptor.
evelopmental origins of disease (Wadhwa et al., 2009).
iven  this perspective, longitudinal studies of health
rajectories are clearly the most suitable approach for
nvestigating developmental cascades over time, though
he  complexity of such cascades requires large samples.
lthough a number of birth cohorts (∼831 to 100,000
articipants each) have been studying antecedents of
ental  health in a prospective fashion, a recent review
uggests that many of these cohorts fall short due to
he  limited “breadth and depth of measurement” neces-
ary  for enhancing our understanding of “how pre- and
erinatal factors and early neurodevelopment relate to
hild  psychopathology” (Thompson et al., 2010). From
he  perspective of the developmental cognitive neurosci-
ntist, the use of magnetic resonance imaging (MRI) for
uantifying brain development provides both the breadth
nd  depth of quantitative phenotypes relevant for mental
ealth. In this regard, the Generation R Study stands out
s  the only birth cohort that has begun serial MR scanning
f  its members. Out of the total of 7893 Generation-R
hildren, 1000 of them have been scanned between 6 and
 years of age and 5000 children will be scanned between
0  and 12 years of age (White et al., 2013).
1.1.2. Transactions across levels (molecules, physiological
ystems, individual behavior, and social groups) are critical
or  our understanding of pathways underlying given health
rajectories. The above example of maternal care (lick-
ng  and grooming) and HPA reactivity illustrates cogently
his  perspective (Zhang et al., 2013). As shown in Fig. 2,
his  cascade begins with an environmental manipulation –
aternal  behavior – measured at the behavioral level (lick-ng  and grooming behaviors), but its effect on the offspring
PA  system can be assessed at a systems level (circu-
ating levels of glucocorticoids), and the molecular levelphosphate; PKA, protein kinase A; NGFI-A, nerve growth factor-inducible
(expression of glucocorticoid receptors in the hippocam-
pus). And consequences on offspring behavior can be
assessed at the behavioral level (self-administration of
cocaine).
This  example from experimental work carried out in
rodents highlights one of the challenges of the human
work: the absence of direct observations of behavior in
large  epidemiological studies – whether in the context of
“exposures” (e.g., maternal behavior) or “outcomes” (i.e.,
offspring  behavior). Instead, we rely on self-reports by the
parents  and the offspring. On the other hand, MR  imag-
ing  provides a rich source of quantitative phenotypes that
can  be used to characterize the state of structural and
functional organization of the offspring brain at a system
level  (phenomics). In addition, carefully designed cognitive
batteries can provide system level assessments of key pro-
cesses  underlying a given behavior (e.g., decision-making
or reward sensitivity tested in the laboratory). Finally, a
sample  of blood (or saliva) can be the source of biologi-
cal material for both the system level (e.g., stress and sex
hormones) and molecular-level (e.g., genetic [genomics]
and epigenetic [epigenomics] variations) assessments. We
have  reviewed the use of the different “omics” sciences in
population-based studies elsewhere (Paus, 2013).
1.1.3. Transactions across organs highlight the impor-
tance of an integrated approach to mental and physical
health. As pointed out above, Alzheimer’s disease (AD)
is  an excellent example of the interplay between cardio-
metabolic and brain health. Over 50% of the population
attributable risk of AD is modiﬁable: diabetes, midlife
hypertension, midlife obesity, smoking, depression, cog-
nitive  inactivity or low educational attainment, and
physical inactivity (Barnes and Yaffe, 2011). As shown
in  Fig. 3, transactions take place across various “organs”:
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 to card
 necrosiFig. 3. Transactions across organs: from eating behavior, through fat cells
high-fat  diet; FFA, free fatty acids; AGT, angiotensinogen; TNF, tumor
rennin-angiotensin-aldosterone system.
from fat tissue to the endocrine system (e.g., insulin
signaling) and low-grade inﬂammation (e.g., cytokines) to
sympatho-activation, kidney function, blood pressure and
cerebro-vascular reactivity, all leading eventually to the
deterioration of brain perfusion and metabolism, loss of
gray  and white-matter and cognitive decline (Paus, 2013).
Furthermore, early environment – and therefore trans-
actions over time – may  play an important role even
in the case of AD; not only in terms of metabolic
programming mentioned above but also vis-à-vis early
brain  development and, in turn, formation of cognitive
and mental-health “reserves” (Stern, 2012). A life-course
approach is therefore warranted not only in the case of
neuro-developmental disorders, such as depression and
addictions, but also in the case of neuro-degenerative dis-
orders,  such as AD (Miller and O’Callaghan, 2008).
1.2. Virtual health trajectories
Given  the need for a life-span approach in studying
health trajectories, birth cohorts are a logical solution.
Without doubt, such cohorts are invaluable sources of
knowledge about developmental cascades. But as pointed
out  above, very few birth cohorts have the necessary
depth of phenotyping (Thompson et al., 2010). Many of
the  cutting-edge tools available today did not exist when
the  original birth cohorts were initiated. At the same time,
longevity of phenotyping tools is inevitably shorter than
that  of the human life span: what is state-of-the-art today
may  be obsolete (or unavailable) tomorrow.
The trans-generational approach represents a possible
“short cut” to achieving (and validating) long-term mod-
els  of health trajectories, while overcoming the challenges
associated with implementing and sustaining long-term
longitudinal studies. In a multi-generational study, theiovascular regulation. Based on (Pausova, 2006). From (Paus, 2013). HFD,
s factor alpha; IL-6, interleukin 6; ROS, reactive oxygen species; RAAS,
successive generations represent stages of disease trajecto-
ries.  In other words, the trans-generational commonalities
– based on shared genes (25–50% in a 3-generation family
vs.  ∼1% in general population) and the shared family envi-
ronment (e.g., geographical location, lifestyle) – become
a  “signature” of a given family on which non-shared
elements (e.g., individual lifestyle, treatments) operate.
By  comparing individuals of the same age, but coming
from families with different “signatures,” we  may  be in
a  position to identify long-term predictors of brain and
cardio-metabolic health.
We have hypothesized that the accuracy of dis-
criminating between a descendant (e.g., daughter or
granddaughter) who  will develop a disease and one who
will  not, tested against the proﬁle (and/or disease status)
of  her ancestor (e.g., mother or grandmother), will be com-
parable  to the discriminative accuracy observed in recent
epidemiological studies but on a shorter time-scale (Paus,
2013).  This hypothesis is based on two  general observa-
tions: (1) most complex traits (and diseases) are likely
caused by a host of factors: multiple genes, various environ-
mental inﬂuences and, of course, combinations of the two;
and  (2) genetic and environmental factors cluster in fam-
ilies,  further enhancing similarity in complex traits across
generations (Fig. 4).
In  the case of mortality risk, as shown by others from
the  Rotterdam Study (Hofman et al., 2011), the predictive
value of a number of lifestyle and physiological characteris-
tics (162 variables in total) is high vis-à-vis the short-term
(<1 year) prediction of mortality (∼0.80) and it decreases
to ∼0.70 when death occurs 15 years post-assessment
(Walter et al., 2012); this is illustrated by the dashed lines in
Fig.  5. If our hypothesis is correct, then Prognosis by Ances-
tor/Pedigree may  be equal to, or better than, a long-term
(30+ years) prognosis by one’s current health status (Fig. 5,
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Fig. 4. Shaping the child’s brain. This schematic diagram illustrates how
nternal  (e.g., nutrition), physical (e.g., pollution, noise, access to parks) an
olid lines). If so, Prognosis by Ancestor/Pedigree will
rovide a glimpse into the future for descendants, as well as
roviding  the basis for speciﬁc interventions and preven-
ive  measures, so as to avoid predicted adverse outcomes.
.  Saguenay Youth Study: overall design
The ﬁrst wave of the SYS cohort (2003–2012) has
ocused on establishing a community-based sample of ado-
escents  (12 to 18 years of age) in which to evaluate
ssociations between the exposure to an adverse prena-
al  environment, brain development and cardio-metabolic
ealth (Pausova et al., 2007). In keeping with the above
rinciples of developmental cascades, the cohort was  set up
o  that detailed information could be collected at different
evels  (behavioral, systemic, molecular) and organs (brain,
dipose  tissue, cardiovascular system, endocrine system).
ver  a period of 10 years, we have collected a rich dataset in
029  adolescents from the Saguenay Lac Saint Jean region
Quebec, Canada). This region is the home of the largest
ig. 5. Risk/resilience proﬁling: virtual validation (dashed lines) and
rognosis by ancestor/pedigree (solid lines). The numbers indicate
ypothesized discriminative accuracy (0.5 = chance, 1 = perfect discrim-
nation).
rom (Paus, 2013).s’ brains contribute to the variations in their children’s environments –
l (neighborhood safety, school friends and role models).
population with a known genetic founder-effect in North
America (De Braekeleer, 1991; De Braekeleer et al., 1998;
Gradie  et al., 1988; Grompe et al., 1994), making it partic-
ularly suitable for studies of complex traits.
As a model of prenatal adversity, we  chose maternal
cigarette smoking during pregnancy (MSP). This choice
reﬂects high prevalence of MSP  in the general popula-
tion; the latest results of the National Survey on Drug
Use and Health (U.S.A.) suggest that smoking during preg-
nancy  has not changed signiﬁcantly between 2002/2003
and 2011/2012, ranging between 18% and 15.9% respec-
tively (Anon., 2013). Smoking during pregnancy has been
associated with a number of behavioral sequelae (Cornelius
and  Day, 2009; Gaysina et al., 2013; Kandel et al., 2009;
Wakschlag et al., 2011), in that offspring of mothers who
smoked cigarettes during pregnancy are more vulnerable
to  developing addictions, likely due to the combination of
prenatal  exposure with other familial (genetic and envi-
ronmental) risks.
We  recruited adolescents in high schools. Over a period
of  10 years, our team has made 28 visits to schools and, in
this  way, contacted a total of 27,190 students (18,127 fami-
lies).  Of the 18,127 families, 5570 (33%) sent a response card
indicating  their interest in the study (3269 families; 59%
of  all responses) or declining further participation (2301
families; 41% of all responses). Based on the inclusion (e.g.,
maternal smoking during pregnancy, 2 or more siblings
per  family) and exclusion (MR  contraindications) criteria
(Supplementary Table I in Pausova et al., 2007), a total of
1801  families (55% of the interested families) were eligible
to  participate in the study; the eligibility was determined
by a research nurse via a structured telephone interview.
Individuals whose mothers smoked during pregnancy (at
least  1 cigarette per day during the second trimester) were
identiﬁed ﬁrst (via a telephone interview with the mother);
then  we selected non-exposed individuals (no smoking for
12  months before pregnancy and during pregnancy) who
134 T. Paus et al. / Developmental Cognitive Neuroscience 11 (2015) 129–144
Table 1
Saguenay Youth Study: Baseline in adolescence (completed).
Domain Tool Phenotypes
Brain MRI  Global and regional volumes; cortical surface & thickness; MTR
Cognition  6-h battery FSIQ, VIQ, PIQ; verbal, visuospatial, working memory;
executive functioning, problem solving, ﬂuency, language,
phonological and motor skills; social cognition
Mental health DPS, GRIP Epidemiological diagnoses; symptom counts
Substance use GRIPado Cigarette smoking, cannabis, alcohol use, drug
experimentation (age of initiation, last 30-days, binge
drinking)
Personality  NEO-PI-R Neuroticism, extroversion, openness, agreeableness,
conscientiousness
Sexual maturation PDS Stages of pubertal development (Tanner stages)
Lifestyle Lerner, 24-h
food  recall
Sleep, energy and nutrient intake, physical activity,
extracurricular activities, sexuality, academic/vocational
aspirations
Family
environment
FamEnvi  Stressful life events, ﬁnancial difﬁculties, SES (family income,
parental  education)
Body  composition Anthropometry,
MRI,
Bioimpedance
Height,  weight, circumferences, skinfolds; subcutaneous,
visceral fat and muscle volumes; fat & muscle mass
Cardiovascular Finometer Beat-by-beat blood pressure and heart rate at rest and in
response  to physical and mental challenges, sympathetic &
parasympathetic  tone
Hormones  Blood Testosterone, estrogen, cortisol
Biochemistry Blood Glucose, insulin, cholesterol, HDL-cholesterol, triglycerides,
leptin,  C-reactive protein, glycerol, free fatty acids
Lipidomics LC-ESI-MS ∼700 lipid species
MTR, magnetization transfer ratio; DPS, DISC Predictive Scales; GRIP, Groupe de Recherche sur l’Inadaptation Psychosociale, adolescent self-assessment of
mental health and substance use developed for the SYS by J. Séguin based on validated National Longitudinal Survey of Children and Youth (NLSCY) and Que-
dolescent self-assessment developed by Richard Lerner. FSIQ Full Scale IQ Rating;
pment Scale; HDL, high-density lipoprotein; LC-ESI-MS, liquid-chromatography
ersion, Openness–Personality Inventory. For details, see Pausova et al., 2007.
Table 2
Saguenay Youth Study: Baseline in parents (completed).
Domain Tool Phenotypes
Family environment FamEnvi Stressful life events, ﬁnancial
difﬁculties,  SES (family income,
parental education)
Mental health GRIPadult Symptom counts (depression,
anxiety,  anti-social behavior)
Substance use GRIPadult Cigarette smoking, alcohol use,
drug experimentation
FamEnvi, questionnaire on family environment developed by the SYS
team; GRIPAdult, self-assessment of mental health and substance use,
as  adapted by colleagues at the Groupe de Recherche sur l’Inadaptation
Psychosociale of the University of Montreal.
Table 3
Wave 1: Baseline in adolescents (completed).
Measure Distribution
N 1029
Number of families 481
Age (years) Mean = 15.02; SD = 1.84
Sex  48% male; 52% female
Exposure to MSP  48% exposed; 52% non-exposed
Household income ≤$20,000 – 13%
$30,000–40,000 – 19%
$50,000–60,000  – 24%
$70,000–80,000  – 20%bec  Longitudinal Study of Child Development (QLSCD) protocols; Lerner, a
VIQ,  Verbal IQ Rating; PIQ, Performance IQ Rating; PDS, Puberty Develo
electrospray-ionization mass-spectrometry; NEO-PI, Neuroticism, Extrav
were matched to the exposed ones by maternal education
and school attended. Note that this matching procedure
was used on an ongoing basis throughout the study; it was
applied  at each high school so that an equivalent number of
“exposed”  and (matched) non-exposed adolescents were
recruited at each school. In this manner, we minimized
differences between the “exposed” and “non-exposed”
adolescents in their families’ socio-economic status. We
used  a family-based design, recruiting a minimum of two
siblings  per family; note that siblings were concordant for
the  exposure status in the majority of families (446/481
families; 93%). Phenotyping of the adolescents took place
over  several sessions (∼15 h in total) and included a num-
ber  of domains detailed in Table 1 (further details in
Pausova et al., 2007 and www.saguenay-youth-study.org);
each adolescent provided a fasting (morning) blood sam-
ple.
During  this initial phase (Wave 1), biological parents of
the  adolescents ﬁlled out a series of questionnaires about
the  family environment and their mental health; the latter
included questions about cigarette smoking, alcohol use,
and  drug experimentation throughout their life (including
current habits and age of onset), and the presence of anti-
social  behavior (at present and during their adolescence;
Table 2). Parents also provided a blood sample for genetic
analyses.In  Table 3, we provide basic demographic information
about the sample of adolescents who underwent the full
assessment during Wave 1. In Table 4, we provide infor-
mation about the lifetime history and current (last 30 days)
≥$85,000  – 24%
Full scale IQ Mean = 104.42; SD = 12.14
SD = Standard deviation; IQ = intelligence quotient; MSP  = maternal smok-
ing  during pregnancy.
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Table 4
Percent of adolescents reporting drug experimentation (lifetime) and current use (last 30 days) for cannabis, alcohol and cigarettes in the SYS adolescents.
N Cannabis
(lifetime)
Cannabis (last
30  days)
Alcohol
(lifetime)
Alcohol (last
30  days)
Cigarettes
(lifetime)
Cigarettes (last
30  days)
Early adolescence
(12–15.9 years)
704 22% 9% 52% 21% 21% 8%
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(16–18 years)
324 55% 20% 
se of the three most common substances: cannabis, alco-
ol  and cigarettes. Note that the current use of cannabis
n  older adolescents (16–18 years) is comparable to that
ound  in other countries among high-school students
Hibell et al., 2012).
Using  deoxyribonucleic acid (DNA) extracted from
he blood samples of the adolescents and their parents,
e have acquired information about single nucleotide
olymorphisms (SNPs) using a genome-wide approach.
he ﬁrst 600 adolescents were genotyped with the
llumina Human610-Quad BeadChip (610K SNPs). The
emaining 424 adolescents and all 971 parents were
enotyped with the Illumina HumanOmniExpress Bead-
hip  (700K SNPs). We  have used imputations to generate
he  same set of markers for the two samples; we
mployed an imputation protocol developed by the
NIGMA Working Group, and imputed genotypes using
MPUTE (www.mathgen.stats.ox.ac.uk/impute), with a ref-
rence  ﬁle created by the ENIGMA2 Genetics Support Team.
his  reference ﬁle is based on the most recent versions of
he  1000 Genomes Project set (Phase 1, Release v3; ∼41M
NPs)  but includes only ∼13M SNPs that are polymorphic
n Caucasians and have been observed more than once in
uropean  populations.
In  addition, we have quantiﬁed the rate of DNA methyla-
ions across 450,000 CpG sites in a subset of the adolescents
n  = 132) and their parents (n = 280); this was accomplished
y hybridizing DNA to the Inﬁnium HumanMethylation450
eadChip (Illumina, San Diego, CA). This chip interrogates
ethylation at >485,000 CpG sites, providing coverage of
99%  RefSeq genes; the CpG sites are targeted across gene
egions  including the promoter, 5′UTR, ﬁrst exon, gene
ody, and 3′UTR, as well as intergenic sequences (Sandoval
t  al., 2011).
Finally, targeted lipidomics proﬁling is currently con-
ucted in all adolescents and their parents. Liquid
hromatography, electrospray ionization mass spectrom-
try  (LC-ESI-MS) is used to assess plasma proﬁles of
700  glycerolipid, glycerophospholipid and sphingolipid
pecies as potential biomarkers of cardiovascular and men-
al  health.
.  Saguenay Youth Study: highlights
Before proceeding with the description of the parent
rm of the SYS cohort (Wave 2: Parents), let us brieﬂy
ighlight some of the published observations made in
ave  1: Adolescents. We  will focus here on ﬁndings rele-
ant  to maternal smoking during pregnancy and addictive
ehavior; our work on sex differences in the maturation
f white matter (Herve et al., 2009; Perrin et al., 2008,1% 65% 38% 22%
2009), puberty-related changes in the face morphology
(Mareckova et al., 2011, 2013) and cardio-metabolic health
(Goodwin et al., 2013; Melka et al., 2013a, 2012; Pausova
et  al., 2010, 2012; Syme et al., 2008, 2009) can be found
elsewhere.
One  of the most common consequences of MSP  is
intra-uterine growth retardation (Lowe, 1959); this is not
surprising  given the multiple effects of cigarette smok-
ing  on the supply of nutrients and oxygen to the fetus
(reviewed in Pausova et al., 2007; Slotkin, 1998). As shown
with  fetal imaging, brain growth does not appear to escape
this  global phenomenon (Anblagan et al., 2013). By the time
the  exposed offspring reaches adolescence, however, the
brain  size appears to be the same as that of non-exposed
adolescents. Nonetheless, we asked whether this is the
case  also for individuals with a particular genetic variation
associated with brain size, as revealed in a genome-wide
association study (GWAS) in the SYS adolescents. We
found that this was  not so: exposed female adolescents
with the KCTD8 risk-variant had smaller surface area of
the  cerebral cortex than non-exposed females without
this variant (Fig. 6; Paus et al., 2012). We  have specu-
lated that this gene-environment interaction reﬂects an
accelerated apoptosis of progenitor cells in the develop-
ing  brains of embryos/fetuses who  possess this particular
genetic variant (Paus et al., 2012). Above and beyond global
brain  growth, we have observed differences between the
exposed  and non-exposed (female) adolescents in the (rel-
ative)  size of the corpus callosum (Paus et al., 2008b)
and the thickness of the orbitofrontal cortex, OFC (Toro
et  al., 2008). We  followed up the latter ﬁnding and asked
whether there is a relationship between the OFC thickness
and  drug experimentation; in this context, we have exam-
ined  the role of the known functional polymorphism in the
BDNF  gene (and the methylation status of its promoters) in
moderating  this relationship (Lotﬁpour et al., 2009; Toledo-
Rodriguez et al., 2010). We  also investigated a relationship
between genetic variations in alpha 6 nicotinic receptor
gene (CHRNA6), striatal volume and drug experimentation
(Lotﬁpour et al., 2010).
Prenatal  exposure to maternal smoking during preg-
nancy is a well-established risk factor for obesity (Al
Mamun  et al., 2006; Ino, 2010; Leary et al., 2006; Oken
et  al., 2005, 2008; Power et al., 2010; Power and Jefferis,
2002; Syme et al., 2010; von Kries et al., 2002; Weng
et al., 2012). In an exposed individual, it increases the
likelihood for developing obesity by 50%, (Ino, 2010; Weng
et  al., 2012). Given this higher risk (odds ratio of 1.5),
and the prevalence of MSP  in the 1960s and 1970s (40%)
and  currently (16%), we  estimated that – at present –
up  to 16% of obesity in middle-aged adults and 7.4% of
136 T. Paus et al. / Developmental Cognitive Neuroscience 11 (2015) 129–144
Fig. 6. Age-adjusted values (Mean ± SE) of brain volume (top), total cortical area (middle) and cortical folding (bottom) in female adolescents exposed (left
column)  and not exposed (right column) to maternal cigarette smoking during pregnancy, all plotted as a function of the KCTD8 genotype (rs716890; GG,
GT  and TT genotypes; G, guanine; T, thymine). The amount of variance (r2) explained by the genotype and statistical signiﬁcance of the genotype effect of
on betweach  phenotype are indicated. Note that we  observed signiﬁcant interacti
and  cortical folding but not on brain volume.
From (Paus et al., 2012).
obesity in children is attributable to MSP. The underlying
mechanisms of the link between MSP  and obesity are
not  clear, however. Our ﬁndings in the SYS suggest that
reward-related mechanisms may  be at play. We  showed
that  MSP  is associated with substantial increases in body
adiposity (Syme et al., 2010), and higher preference for fat
accompanied by smaller amygdalae volumes (Haghighi
et  al., 2013). In a genome-wide association study, we also
showed  that dietary preference for fat (as well as body
adiposity) is associated with genetic variation in the opioid
receptor mu  1 gene (OPRM1) (Haghighi et al., 2014). Finally,
we  have demonstrated that MSP  is associated with modiﬁ-
cations  of DNA methylation that persist into adolescence of
the  exposed offspring (Lee et al., 2014a), and that some ofeen the KCTD8 genotype (rs716890) and “exposure” on total cortical area
these  modiﬁcations are present in OPRM1, and may inhibit
expression of the protective (fat intake-lowering) allele of
this  gene (Lee et al., 2014b). Taken together, these observa-
tions  suggest (a) the presence of relationships between the
brain-reward system, dietary preference for fat and obe-
sity;  (b) perturbations of these relationships by MSP  and
genetic  variations in OPRM1; and (c) DNA methylation as
a  possible molecular mechanism underlying interactions
between environment (MSP) and genes (OPRM1).
Apart from the above fat-preference angle, we  also
found that a genetic variant of the FTO gene, the best
known genetic risk factor for obesity, predicts an inverse
relationship between total brain volume and fat body
mass (Melka et al., 2013b). We  have suggested that,
gnitive Neuroscience 11 (2015) 129–144 137
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Table 5
Wave 1: Baseline in parents (completed).
Measure Distribution
N 962
Number of families 481
Age (years) Mean = 43.33; SD = 4.58
Sex  50% male; 50% female
Household income ≤$20,000 – 13%
$30,000–40,000 – 19%
$50,000–60,000  – 24%
$70,000–80,000  – 20%
≥$85,000  – 24%
Education No high school – 1%
Some  high school – 15%
High  school – 52%
College  degree – 19%
Bachelors  – 9%
4.3. Cognitive abilities
Cognitive  abilities are assessed using a vali-
dated web-based battery for the assessment of
Table 6
Wave  1: Parents. Substance use and mental health.
Mothers (%) Fathers (%)
Smoking (current/former/never) 32/42/26 31/41/29
Cannabis (last 12 months) 5.2 11.2T. Paus et al. / Developmental Co
iven the completion of overall brain growth in early
hildhood, these effects might have their origins during
arly development and reﬂect a differential commitment
f progenitor cells to ectoderm (brain) or mesoderm (fat
issue).  Finally, we began exploring the differential impact
f  visceral fat on the adolescent’s brain (Schwartz et al.,
014)  and cognition (Schwartz et al., 2013).
Overall, the initial ﬁndings obtained in Wave 1 of the
YS  cohort revealed a number of associations between
SP, brain, and addictive behavior of adolescents in the
ontext  of both drug experimentation and dietary fat pref-
rence.  Although observational studies cannot attribute
olely such associations to MSP  (D’Onofrio et al., 2012),
uman studies with genetically sensitive research designs
Gaysina et al., 2013) and preclinical studies of prena-
al  exposure to nicotine (Franke et al., 2008) suggest that
hese  prenatal exposures do play a role in shaping mental-
ealth trajectories. Furthermore, careful consideration of
otential  confounders, such as maternal education and
lcohol  use during pregnancy, when examining the rela-
ions  between externalizing behavior and substance use
Lotﬁpour et al., 2014) or the speciﬁcity of some of the
bserved structure–function relationships (e.g., correla-
ion  between the amygdala volume with fat preference
ut not with alcohol use; Haghighi et al., 2013) suggest
hat these associations are not due to global phenomena
such as “poverty” or an “addictive personality” of the
arents). Finally, it is important to note that we  have
bserved a number of gene-exposure interactions that
rgue  against general confounding: with the equal distribu-
ion  of a given genetic variant between the “exposed” and
non-exposed” adolescents, such gene–environment inter-
ctions  point to speciﬁc molecular pathways mediating
ssociations between MSP  and a given phenotype (CHRNA6
Lotﬁpour et al., 2010); KCTD8 (Paus et al., 2012); OPMR1
Lee  et al., 2014a)). In general, the use of genetic variations
o  ascribe causality to observations made in large epidemi-
logical studies has been helpful in a number of domains
Smith and Ebrahim, 2003). In the context of addiction,
e employ this approach in secondary analyses carried
ut  by the members of a consortium called “The Causal
nalysis Research in Tobacco and Alcohol (CARTA)”, which
ncludes  30 studies, with a total of 150,000 participants
http://goo.gl/dkXQyH).
. Saguenay Youth Study: parent arm
As pointed out above, we have obtained basic infor-
ation about the mental health and substance use of the
iological parents at the time of recruitment of the adoles-
ents,  as well as a blood sample for genetic and epigenetic
nalyses. In Tables 5 and 6, respectively, we provide summ-
ries  of demographic information about the parents, their
ental  health and substance use at the time of the initial
ecruitment (Wave 1).
In 2012, we initiated Wave 2: Parents of the SYS cohort.
his wave focuses on deep phenotyping of the biological
arents of the SYS adolescents. Parents complete a series
f  on-line questionnaires and visit our phenotyping unit
or  MRI  scans of the brain and abdominal fat, blood sample
or  biochemistry and lipidomics analyses, as well as forMasters  or doctorate – 3%
Unknown – 1%
SD = standard deviation.
cardio-metabolic and cognitive assessments (Table 7). The
visit  lasts ∼4 h.
4.1. Internet-based assessments
As  indicated in Table 7, we  are re-administering fam-
ily  environment, lifestyle and mental-health/substance
use questionnaires, as well as several new question-
naires focusing on parenting, sleep, personality and various
addictive behaviors, such as food, gambling and internet
addictions.
4.2.  Face-to-face assessment
The  visit takes place in the morning and lasts ∼4 h:
it includes a draw of blood (after overnight fasting) for
future “omics” analyses, a structured psychiatric inter-
view,  cognitive assessment, MRI  and cardiovascular/body-
composition sessions, each lasting ∼60 min. For the
psychiatric interview, we  use the Mini-International Psy-
chiatric  Interview (MINI Plus, Sheehan et al., 1998)
administered by a trained research assistant. MINI Plus is a
validated,  structured psychiatric interview for current and
lifetime  DSM-IV and ICD-10 psychiatric disorders. We  have
also  added the nicotine dependence module from Semi-
Structured Assessment for the Genetics of Alcoholism,
SSAGA (Hesselbrock et al., 1999).Alcohol (binge drinkinga) 49.8 71.15
Depression symptoms (90th percentile) 10.6 9.7
Anxiety symptoms (90th percentile) 12.5 6.9
a 5 or more drinks on one occasion (at least once in the last 12 months).
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Table 7
Wave  2: parents (ongoing).
Domain Tool Phenotypes
Brain MRI  Global and regional volumes; cortical surface & thickness;
white-matter hyperintensities; magnetization transfer
ratio;  diffusion tensor imaging; resting-state functional
MRI
Cognition Cambridge Brain Sciences Platform Executive functioning; attention; learning & memory;
reasoning; spatial skills
Mental  health MINI International Neuropsychiatric Interview;
Mental Health and Addiction Questionnaire; ASR;
CES-D; Family History Screen
Depression, anxiety, attention deﬁcit hyperactive disorder,
antisocial  personality disorder; post-traumatic stress
disorder; obsessive compulsive disorder; alcohol and
substance  dependence, bulimia, anorexia; family history of
psychiatric  disorders
Substance  use & addiction Mental Health and Addiction Questionnaire; YFAS;
FNDS; AUDIT; SRE; ESPAD; IAT; SOGS
Cigarette smoking, alcohol and drug use, gambling,
internet addition, food addiction
Personality  NEO-FFI Neuroticism, extroversion, openness, agreeableness,
conscientiousness
Lifestyle Life Experiences Questionnaire; PBI; Hand
Preference
Family characteristics; education; socio-economic status;
physical  activity; sexual activity; parental style; hand
laterality
Sleep  PSQI; ESS Sleep quality, latency, duration, efﬁciency and
disturbances; daytime sleepiness
Body  composition Anthropometry, MRI, Bioimpedance Height, weight, circumferences, skinfolds; subcutaneous,
visceral fat and muscle volumes; fat & muscle mass
Cardiovascular Finometer Beat-by-beat blood pressure and heart rate at rest and in
response  to physical and mental challenges, sympathetic &
parasympathetic tone
Lung  Function Spirometer Forced vital capacity, forced expiratory volume
Diet 24-h food recall Energy  and nutrient intake
Medical  history Medical Questionnaire Personal and family history of: cancer, hypertension,
diabetes, heart disease, lipid disease, psychiatric disorders,
addiction; reproductive and sexual health; medications
Hormones Blood Testosterone, estrogen, cortisol
Biochemistry Blood Lipid proﬁle (TG, TC, HDL-C, LDL-C), glucose, insulin, free
fatty  acids, glycerol, C-reactive protein
Lipidomics LC-ESI-MS (Blood) >700 lipid species
MRI  = magnetic resonance imaging; Cambridge Brain Sciences Platform (Hampshire, Highﬁeld, Parkin, & Owen, 2012); MINI International Neuropsychiatric
Interview  (Sheehan et al., 1998); Mental Health and Addiction Questionnaire (Adapted from the Ontario Health Study www.ontariohealthstudy.ca and the
Wave-1 questionnaire developed by the SYS team); ASR = Adult Self Report (Achenbach & Rescorla, 2003); CES-D = Center for Epidemiology Studies Depres-
sion  Scale (Radloff, 1977); Family History Screen (Weissman et al., 2000); YFAS = Yale Food Addiction Scale (Gearhardt et al., 2009); FNDS = Fagerström’s
Nicotine Dependence Scale (Heatherton et al., 1991); AUDIT = Alcohol Use Disorder Identiﬁcation Test (Barbor et al., 1992); SRE = Subjective Response to
Ethanol  (Schuckit et al., 1997); ESPAD = European School Survey Project on Alcohol and Other Drugs (Hibell et al., 2012); IAT = Internet Addiction Test
(Widyanto and McMurran, 2004); SOGS = South Oaks Gambling Screen (Lesieur & Blume, 1987); NEO-FFI = NEO-Five Factor Inventory (Costa and McCrae,
1992); Life Experiences Questionnaire (Adapted from the Ontario Health Study www.ontariohealthstudy.ca and the Wave-1 questionnaire developed by the
SYS  team); PBI = Parental Bonding Instrument (Parker et al., 1979); Hand Preference (Adapted from Crovitz and Zener (1962)); PSQI = Pittsburgh Sleep Qual-
ity Index (Buysse et al., 1989); ESS = Epsworth Sleepiness Scale (Johns, 1991); 24-h Food Recall (Buzzard et al., 1996); Medical Questionnaire (Adapted from
the  Ontario Health Study www.ontariohealthstudy.ca); TG = triglycerides; TC = Total Cholesterol; HDL-C = High density lipoprotein-cholesterol; LDL-C = low
density lipoprotein-cholesterol; LC-ESI-MS = liquid chromatography electrospray ionization mass spectrometry.cognition developed by Drs. Owen and Hampshire
(www.cambridgebrainscience.com). The battery is com-
prised  of 12 computer-based tests of executive function,
memory, learning and attention, and takes ∼35 min
to  complete. Population norms are available from two
large-scale public trials involving more than 100,000
participants (Hampshire et al., 2012).
4.4. The MRI  session
The  MRI  session takes place at a private MR  clinic
in Chicoutimi, which is equipped with a Siemens 1.5T
(Avanto) scanner. A 60-min MR  session includes the fol-
lowing  imaging protocols. Structural MRI  of the brain: T1W,
1-mm,  isotropic images acquired with a 3D fast RF-spoiled
gradient echo scan. Magnetization-transfer (MT)  ratio: MTdata  are acquired using a dual acquisition (3D RF-spoiled
gradient echo scan) with and without an MT  saturation
pulse (3-mm thick axial slices, 1 × 1 mm  in-plane res-
olution). Diffusion Tensor Imaging (DTI): DTI is used to
assess  the structural properties of white matter. Diffu-
sion  encoding is achieved using a single-shot, spin-echo,
echo planar sequence with twice-refocused balanced diffu-
sion  encoding gradients (64 diffusion-encoding directions,
3-mm thick axial slices, 2.3 mm × 2.3 mm in-plane res-
olution). Resting-state functional MRI  is acquired over a
period  of 12 min  (260 volumes, 4-mm thick axial slices,
3.5  mm  × 3.5 mm in-plane resolution, eyes closed). Finally,
abdominal scans are acquired using heavily T1-weighted,
spin-echo scans (30 axial 10-mm thick slices, 1-mm
gap, 0.9 mm × 0.9 mm in-plane resolution) extending from
about  the bottom of the liver to the umbilicus level.
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.5. The cardiovascular/body composition session
This session takes place at ECOGENE-21/Community
enomic Medicine Center in Chicoutimi. The following pro-
ocol  is identical to the one used to collect equivalent data in
dolescents  during Wave 1. Blood pressure (BP) is measured
oth  under standard clinical conditions and during a 52-
in  cardiovascular reactivity protocol. (a) Standard clinical
onditions: BP is measured at rest for at least 10 min  while
eated  with a standard occlusion cuff (“The fourth report
n  the diagnosis, evaluation, and treatment of high blood
ressure in children and adolescents,” 2004). This measure-
ent  is done at the beginning and end of the cardiovascular
eactivity protocol described next. (b) Cardiovascular reac-
ivity  protocol lasts 52 min  and mimics daily-life activities,
ncluding changes in posture and mental stress; BP and a
umber  of other cardiovascular parameters are measured
eat-by-beat using a non-invasive hemodynamic monitor,
inometer (FMS Finapres, Amsterdam, The Netherlands;
ee below). The posture test consists of 3 periods dur-
ng  which the participant rests in a supine position for
0  min, stands for 10 min, and sits for 10 min. The mental
tress test involves a 30-s explanation administered 5 min
rior  to a 2-min sequence of 23 simple arithmetic prob-
ems,  each presented for 5 s; the problems include simple
ath  additions or subtractions followed by simple mul-
iplications or divisions. The level of difﬁculty increases
rogressively with time to ensure some failures for all par-
icipants; all answers are recorded. The math sequence is
ollowed  by a 10-min period of resting in a sitting posi-
ion.  Throughout this protocol, a Finometer is used to
ecord  continuously the ﬁnger blood ﬂow. The Finometer
erives beat-by-beat brachial systolic and diastolic BP from
he  reconstructed and level-corrected ﬁnger blood-ﬂow
aveform. The Finometer is a reliable device for track-
ng  BP in adults and children older than six years (Parati
t  al., 1989; Tanaka et al., 1994) and the precision of BP
easurement with this device meets the requirements of
he  American Association for the Advancement of Medical
nstruments (Guelen et al., 2008; Westerhof et al., 2002).
ody  Composition: Body weight, height, six circumferences
upper arm, waist, hips, proximal thigh, middle thigh and
istal  thigh), and ﬁve skinfolds (triceps, biceps, subscapu-
ar,  suprailiac and mid-thigh) are measured according to
tandard  procedures (Pausova et al., 2001). Bioelectrical
mpedance is used to measure total body fat, total body
ater and fat-free mass. Participants are asked to refrain
rom  caffeine, alcohol, and vigorous activity 24 h before
he  test. The actual measurement is made after a 20-min
tabilization period during which the participants rest in
 supine position. These measures are complemented by
he  quantiﬁcation of subcutaneous and visceral fat derived
rom  abdominal MRIs (see above). Given the high preva-
ence  of smokers in this cohort (due to the ascertainment
f the original sample, with half of the mothers smoking
uring pregnancy), we have also included assessment of
ung  function using spirometry. Using a spirometer (Min-
Spir  by Medical International Research [MIR], Rome, Italy
www.spirometry.com);  MiniSpir User’s Manual. Manual
evision 1.3. 2006. Medical International Research; User’s
anual  Code 980255) we measure the amount and theeuroscience 11 (2015) 129–144 139
rate  at which a participant exhales in a single breath. The
standard spirometric test requires the participant to exhale
as  forcefully as possible after taking a full inspiration. This
measures the participant’s forced vital capacity as well as
their  forced expiratory volume in one second.
As of September 2014, we  have acquired full datasets in
573  parents. We  are also in the process of contacting the
living  grandparents of the adolescents in order to obtain
a  saliva sample (for genetic and epigenetic analyses) and
basic  information about their mental health and substance
use.  Finally, we have obtained approval for receiving infor-
mation  contained in death certiﬁcates for the deceased
parents and grandparents of the SYS adolescents.
5. Large developmental cohorts: design strategies
and challenges
The  Saguenay Youth Study (and its parental arm) is one
among a growing number of large community-based stud-
ies  (IMAGEN (Schumann et al., 2010); Generation R (White
et  al., 2013); PING (Fjell et al., 2012)) that combine brain
imaging with genetics, as well as with a detailed assess-
ment of cognition, mental health and family environment.
The overarching goal of these studies is to gain insights
into factors (and mechanisms) shaping the brain in typ-
ically  developing children and adolescents. These studies
face  similar challenges with regards to the ascertainment
of their participants (and representativeness of the sam-
ples),  the choice of neuroimaging protocols (structural vs.
functional), assessments of cognition and mental health,
and  involvement of other family members. We  will address
brieﬂy  some of these issues in the following text (for details,
see  Paus, 2010, 2013).
Ideally,  ascertainment of participants in population-
based studies should be free of selection biases, thus
creating conditions for generating data representative of
the  general population – “a representative brain” (Falk
et  al., 2013). As we  pointed out elsewhere, previous imag-
ing  cohorts used different recruitment strategies (samples
of  convenience vs. census-based sampling) and exclusion
criteria (MR  contraindications only vs. screening out chil-
dren  with any personal and family-based risk factors); not
surprisingly, some of these strategies yielded “supernor-
mal” samples (Paus, 2010). In the Saguenay Youth Study,
we  have carried out recruitment in all public high schools
in  the region and excluded from participation only adoles-
cents  with MRI  contraindications and serious conditions
likely to affect the brain (e.g., epilepsy) or heart (e.g., heart
defects) development. By design, the sample is enriched
by  individuals born to mothers smoking cigarettes during
pregnancy (50% vs. ∼20% expected in general population).
Other – more subtle – biases include the requirement of
having siblings and being able to contact both biological
parents. The latter conditions are, however, unlikely to
reduce  representativeness of the sample, as the mean num-
ber  of children per family in the general population is 1.5
(Quebec, 2014), and the two-parent requirement did not
demand  cohabitation. Recent replications of the relation-
ship  between externalizing behavior and substance use
during  adolescence in two geographically and culturally
distinct samples recruited using very different strategies,
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Table 8
An  example of a 60-min MR  protocol enabling one to characterize a number of structural and functional properties of the human brain. From Paus, 2013.
MRI sequence Time (min) Structure and physiology
T1-weighted 10 Volumes, thickness, folding, shape, tissue density
T2-weighted 4 White matter hyperintensities (number, volume, location)
Diffusion tensor imaging 12 Fractional anisotropy, mean diffusivity, track delineation
Magnetization transfer 8 Myelination index
Perfus
Sponta
Brain rArterial  spin labeling 5 
Resting state functional 8 
Paradigm-based functional 6–10 
namely the Saguenay Youth Study and the Northern
Finland Birth Cohort 1986, suggest that ﬁndings obtained
in  our sample are generalizable (Lotﬁpour et al., 2014).
Brain  imaging represents a unique tool allowing one to
obtain  a wide array of quantitative phenotypes (Table 8).
A  number of considerations are at play when choosing
speciﬁc MR  sequences. For example, studies of typi-
cally developing children and adolescents are more likely
to  include scans sensitive to changes in myelination
(e.g., magnetization transfer ratio or myelin water frac-
tion,  Dean et al., 2014) rather than those sensitive to
white-matter hyperintensities, which are more common
in  the aging brain (e.g., T2 ﬂuid attenuated inversion
recovery [FLAIR]). But perhaps the most relevant con-
siderations relate to the trait (vs. state) qualities of a
given  measure; after all, we base most of our develop-
mental work on the assumption that genes and early
environments shape brain function and structure in a
stable  and long-term manner. Therefore, test–retest reli-
ability  of imaging-derived measures is paramount. Not
surprisingly, various metrics derived from (multi-modal)
structural images show high test–retest reliability. For
example, Wonderlick and colleagues (Wonderlick et al.,
2009)  have evaluated test–retest reliability (two sessions,
2  weeks apart), and the inﬂuence of several acquisition
parameters (same 3T scanner), for a number of morpho-
metric measures derived from T1-weighted images by
FreeSurfer. They found that the reliability – estimated
with intra-class correlation coefﬁcients (ICCs) – was “excel-
lent”  for most measures; with the exception the globus
pallidus, all ICCs values were above 0.95. The test-retest
reliability of DTI-based measures appears to vary across
the  measures and ﬁber tracts. For example, Wang et al.
(2012)  found excellent reliability (ICCs > 0.75) for the mean
length  of the corpus callosum and the uncinate fasciculus,
and fair reliabilities (ICCs between 0.4 and 0.75) for frac-
tional  anisotropy in most ﬁber tracts. On the other hand,
test–retest reliability of data obtained with fMRI has been
characterized as “fair” (ICC: 0.4–0.75) in adults and ado-
lescents, and “poor” (ICC < 0.4) in children; it is lower in
regions  with weak “activation”, as revealed by group t-
maps  (Caceres et al., 2009; Koolschijn et al., 2011; Plichta
et  al., 2012). The relatively low test–retest reliability of
functional data is likely related to a number of factors,
including the fact that the fMRI signal is an indirect measure
of  brain activity, its measurement is affected by a number
of  noise-generating factors (e.g., head motion, physiolog-
ical  “noise” related to respiration and cardiac cycle) and,
most  importantly, by the state of the participant dur-
ing  scanning. The latter factors, such as inter-individualion
neous cerebral networks; functional connectivity
esponse associated with speciﬁc stimuli/tasks; functional connectivity
and session-by-session variations in task-related behav-
ior  (performance, attention) and general state of arousal
(anxiety, sleepiness) are very difﬁcult to assess and con-
trol,  thereby adding signiﬁcant error to the measurement of
the  functional phenotype. For the above reasons, we advo-
cate  imaging protocols that put emphasis on multi-modal
imaging of brain structure. We  consider brain structure “a
window  into the individual’s life history”, a notion sup-
ported  by the wealth of imaging data on experience-related
brain plasticity (Lovden et al., 2013).
Brain imaging (and genetic) data alone are insufﬁcient
for tracking trajectories in brain development. A signiﬁ-
cant  time commitment must be made to the assessment of
cognition  and mental health. In the Saguenay Youth Study,
for  example, we  have spent ∼8 h of the participant’s time
in  these domains. Given a large variety of approaches and
available tools, only broad recommendations can be made.
When  assessing cognition, we  have used a combination
of standardized (e.g., WISC-III) and computer-based (e.g.,
auditory processing) tools combined in two 3-h sessions
(adolescents). In adults, we  have decided to use a 1-h (stan-
dardized) battery of cognitive tests. In the mental-health
domain, we have focused on self-reported symptoms
rather than using a diagnosis-driven (psychiatric-interview
based) approach. Conceptually, this strategy is consistent
with a move away from categorical deﬁnitions of psychi-
atric  disorders, as deﬁned in the Diagnostic and Statistical
Manual of Mental Disorders (DSM), and toward symptoms
as  a preferred level of analysis (Borsboom et al., 2011).
From a methodological standpoint, self-reports are a rich
source  of reliable information, especially in the context of
substance  use (Sobell and Sobell, 1990).
Finally, any developmental study must consider the
caregivers. As illustrated in Fig. 4, parents are the main
source of genetic and environmental inﬂuences on the
developing brain. For this reason, we have obtained
parental DNA and basic information about the mental
health of the parents (including anti-social behavior dur-
ing  their adolescence) in Wave 1 of the Saguenay Youth
Study, and have embarked on deep phenotyping of the
parents in Wave 2. Parents are also a key source of infor-
mation about the life events encountered by their children
at  different stages of development; prospective longitudi-
nal  birth cohorts, such as the Avon Longitudinal Study of
Parents  and Children (Boyd et al., 2013), Northern Finland
Birth  Cohort 1986 (Taanila et al., 2004) or Generation R
(Jaddoe  et al., 2010) are in an advantageous position to
use  such information to predict the state of brain devel-
opment (and mental health) at later point in the lives of
their  participants.
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. Conclusions
As pointed out in Introduction (Section 1.1), the life-
pan  perspective on health trajectories reﬂects the concept
f  developmental cascades: transactions occurring over
ime,  as well as across systems and organs. The Sague-
ay Youth Study and its parent arm attempts to integrate
etailed information about brain and cardio-metabolic
ealth acquired at the system and molecular levels in a
amily-based multi-generational context. We  hope that the
ichness  of the dataset will allow us to contribute toward
urrent efforts aimed at distinguishing the key processes of
ealthy  trajectories from those leading to common chronic
isorders of the brain and body.
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